6609 Stock Overview
Researches, develops, manufacture, and sells neuro-interventional medical devices in Mainland China.
| Snowflake Score | |
|---|---|
| Valuation | 3/6 |
| Future Growth | 5/6 |
| Past Performance | 0/6 |
| Financial Health | 6/6 |
| Dividends | 0/6 |
Shanghai HeartCare Medical Technology Corporation Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | HK$18.04 |
| 52 Week High | HK$40.50 |
| 52 Week Low | HK$15.64 |
| Beta | 0.74 |
| 1 Month Change | -6.82% |
| 3 Month Change | -2.49% |
| 1 Year Change | -53.20% |
| 3 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | -86.02% |
Recent News & Updates
We're Not Very Worried About Shanghai HeartCare Medical Technology's (HKG:6609) Cash Burn Rate
Jan 23
Recent updates
We're Not Very Worried About Shanghai HeartCare Medical Technology's (HKG:6609) Cash Burn Rate
Jan 23Shanghai HeartCare Medical Technology Corporation Limited (HKG:6609) Shares May Have Slumped 27% But Getting In Cheap Is Still Unlikely
Aug 30Companies Like Shanghai HeartCare Medical Technology (HKG:6609) Are In A Position To Invest In Growth
Aug 09Companies Like Shanghai HeartCare Medical Technology (HKG:6609) Are In A Position To Invest In Growth
May 07We're Hopeful That Shanghai HeartCare Medical Technology (HKG:6609) Will Use Its Cash Wisely
Nov 29Shareholder Returns
| 6609 | HK Medical Equipment | HK Market | |
|---|---|---|---|
| 7D | 0.3% | -5.7% | -2.3% |
| 1Y | -53.2% | -43.7% | 0.3% |
Return vs Industry: 6609 underperformed the Hong Kong Medical Equipment industry which returned -43.7% over the past year.
Return vs Market: 6609 underperformed the Hong Kong Market which returned 0.3% over the past year.
Price Volatility
| 6609 volatility | |
|---|---|
| 6609 Average Weekly Movement | 6.8% |
| Medical Equipment Industry Average Movement | 7.5% |
| Market Average Movement | 7.3% |
| 10% most volatile stocks in HK Market | 15.7% |
| 10% least volatile stocks in HK Market | 3.8% |
Stable Share Price: 6609 has not had significant price volatility in the past 3 months.
Volatility Over Time: 6609's weekly volatility (7%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2016 | 368 | Guohui Wang | www.heartcare.com.cn |
Shanghai HeartCare Medical Technology Corporation Limited researches, develops, manufacture, and sells neuro-interventional medical devices in Mainland China. The company offers ischemic stroke thrombectomy devices, such as Captor thrombectomy device, and aspiration catheter and pump; intracranial stenosis treatment devices comprising intracranial drug-eluting balloon catheter and embolization protection system; hemorrhagic stroke treatment devices, including coil embolization assistant stent and flow diverter device; and ischemic stroke prevention devices, such as LAA occlude. It also provides vascular access devices comprising distal access catheter, microcatheter, balloon guiding catheter, vascular closure device, support catheter, neuro-interventional microcatheter, micro guidewire, microcatheter for coiling, microcatheter for flow diverter device, and navigation catheter.
Shanghai HeartCare Medical Technology Corporation Limited Fundamentals Summary
| 6609 fundamental statistics | |
|---|---|
| Market cap | HK$685.78m |
| Earnings (TTM) | -HK$101.45m |
| Revenue (TTM) | HK$250.72m |
2.7x
P/S Ratio-6.8x
P/E RatioIs 6609 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 6609 income statement (TTM) | |
|---|---|
| Revenue | CN¥232.34m |
| Cost of Revenue | CN¥80.55m |
| Gross Profit | CN¥151.79m |
| Other Expenses | CN¥245.81m |
| Earnings | -CN¥94.01m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | -2.46 |
| Gross Margin | 65.33% |
| Net Profit Margin | -40.46% |
| Debt/Equity Ratio | 0% |
How did 6609 perform over the long term?
See historical performance and comparison